{"url_path":"/sec/pali/8-k/2026-06-11/item-5-03","section_key":"item-5-03","section_title":"Item 5.03 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-11","source_url":"https://www.sec.gov/Archives/edgar/data/1357459/0001493152-26-028322-index.html","accession_number":"0001493152-26-028322","cik":"0001357459","ticker":"PALI","issuer_name":"PALISADE BIO, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1357459/0001493152-26-028322-index.html","primary_entity_key":"0001357459","primary_entity_name":"PALISADE BIO, INC."},"word_count":151,"has_tables":true,"body_markdown":"**Item\n5.03**\n**Amendments\nto Articles of Incorporation or Bylaws; Change in Fiscal Year**\n\n \n\nAs\nreported below under Item 5.07, at the Annual Meeting on June 10, 2026, the Company’s stockholders approved an amendment to the\nCompany’s Amended and Restated Certificate of Incorporation to increase the total number of authorized shares of common stock from\n300,000,000 shares to 450,000,000 shares.\n\n \n\nOn\nJune 11, 2026, the Company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “Amendment”)\nwith the Secretary of State of the State of Delaware to increase the number of authorized shares of common stock from 300,000,000 shares\nto 450,000,000 shares. The Amendment became effective upon filing.\n\n \n\nThe\nforegoing description of the Amendment is not complete and is qualified in its entirety by reference to the full text of the Amendment,\na copy of which is attached hereto as Exhibit 3.1 and incorporated herein by reference."}